Correlation Between Quantum Genomics and OSE Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and OSE Pharma SA, you can compare the effects of market volatilities on Quantum Genomics and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and OSE Pharma.

Diversification Opportunities for Quantum Genomics and OSE Pharma

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Quantum and OSE is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and OSE Pharma go up and down completely randomly.

Pair Corralation between Quantum Genomics and OSE Pharma

Assuming the 90 days trading horizon Quantum Genomics SA is expected to generate 0.32 times more return on investment than OSE Pharma. However, Quantum Genomics SA is 3.1 times less risky than OSE Pharma. It trades about -0.28 of its potential returns per unit of risk. OSE Pharma SA is currently generating about -0.3 per unit of risk. If you would invest  7.61  in Quantum Genomics SA on August 23, 2024 and sell it today you would lose (0.40) from holding Quantum Genomics SA or give up 5.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Quantum Genomics SA  vs.  OSE Pharma SA

 Performance 
       Timeline  
Quantum Genomics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.
OSE Pharma SA 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OSE Pharma SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, OSE Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Quantum Genomics and OSE Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quantum Genomics and OSE Pharma

The main advantage of trading using opposite Quantum Genomics and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.
The idea behind Quantum Genomics SA and OSE Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing